
Palantir Rises, Caterpillar Falls, Hims & Hers Drops on Earnings, Vertex Plunges on Drug Results
Stock Movers
00:00
Healthcare Stocks Under Pressure: Palantir and Aex's Challenges
This chapter examines the recent struggles of Palantir and Aex in the healthcare sector, highlighting Palantir's failed partnership and legal issues with Novo Nordisk, as well as Aex's setback with the FDA over their painkiller. These events have significantly impacted their stock performance and business strategies.
Play episode from 04:14
Transcript


